cjc 1295 no dac ipamorelin 5 5 CJC-1295 & 10mg (No DAC) Blend CJC 1295 No DAC 5mg/Ipamorelin

The mobile phase comprised of (A) 10 mM ammonium formate in 60% aqueous acetonitrile containing 0.1% formic acid and (B) 10 mM ammonium formate in 9:1 mixture of isopropanol and acetonitrile with a 0.5 mL/min flow rate maintained during a 20 min run

As of 2026, neither compound has FDA approval, limiting prescribing to research contexts or off-label use by physicians specializing in obesity medicine or endocrinology

Despite expanding therapeutic options, 10-20% of patients still require proctocolectomy due to medically refractory disease [9]

Category 1 status simply means that the FDA does not currently intend to take enforcement action against pharmacies that compound these substances